Inicio / Hematología / Abstracts de hematología / Changes in treatment landscap…

Changes in treatment landscape of relapsed or refractory multiple myeloma and their association with mortality: Insights from German claims database

0 / 5 (0 votos)
Changes in treatment landscape of relapsed or refractory multiple myeloma and their association with mortality: Insights from German claims database

European Journal of Hematology

Fecha de publicación: 28 de septiembre

DOI: https://doi.org/10.1111/ejh.13523

Autores: Christof Scheid, Igor W. Blau, Leopold Sellner, Boris A. Ratsch, Edin Basic

Background: Emerging treatments for relapsed or refractory multiple myeloma (rrMM) have led to increasing options for many patients. This study aimed to assess changes in utilization of these options in Germany with a focus on modern triplet regimens including new agents, such as carfilzomib, ixazomib, elotuzumab and daratumumab, and to evaluate whether this had an impact on rrMM‐related outcomes over time.

Leer más

Comentarios

Para dejar un comentario antes debes iniciar sesión:

¿No tienes una cuenta?

Regístrate a través de éste enlace.